Table 2 Ganglion cell-inner plexform layer thickness and macular microvasculature parameters in each group.
Control group | HTN group | HTNR group | P value | |
|---|---|---|---|---|
GC-IPL | ||||
Average | 83.5 ± 5.7 | 82.1 ± 6.2 | 75.9 ± 10.7 | < 0.001 |
Superior | 84.5 ± 6.6 | 82.8 ± 6.6 | 78.1 ± 12.4 | 0.005 |
Superotemporal | 82.2 ± 6.0 | 81.7 ± 6.3 | 74.7 ± 10.5 | < 0.001 |
Inferotemporal | 83.6 ± 5.9 | 82.6 ± 6.5 | 73.6 ± 11.2 | < 0.001 |
Inferior | 81.1 ± 6.7 | 79.9 ± 6.5 | 73.6 ± 12.9 | < 0.001 |
Inferonasal | 83.6 ± 6.7 | 81.5 ± 7.3 | 76.1 ± 11.6 | < 0.001 |
Superonasal | 85.6 ± 6.6 | 84.1 ± 7.2 | 79.4 ± 13.8 | 0.021 |
Microvasculature | ||||
Central VD | 10.0 ± 2.6 | 8.7 ± 2.7 | 10.0 ± 2.7 | 0.001 |
Inner VD | 21.8 ± 1.3 | 20.9 ± 1.3 | 20.7 ± 1.6 | < 0.001 |
Full VD | 20.5 ± 1.3 | 19.6 ± 1.4 | 19.5 ± 1.6 | 0.001 |
Central PD | 17.6 ± 5.1 | 15.1 ± 4.9 | 17.6 ± 4.7 | 0.001 |
Inner PD | 39.0 ± 2.2 | 37.8 ± 2.3 | 37.7 ± 2.7 | 0.010 |
Full PD | 36.3 ± 3.0 | 35.3 ± 2.4 | 35.5 ± 2.7 | 0.078 |
GC-IPL/VD ratio | 4.10 ± 0.33 | 4.20 ± 0.40 | 3.88 ± 0.56 | < 0.001 |